University of Cambridge > > Materials Chemistry Research Interest Group > Nanotechnology for Medicine

Nanotechnology for Medicine

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Sian Bunnage.

BP Lectures 2013

Nanometer-sized carbon carriers, hydrophilic carbon clusters (HCCs), have been developed for targeted drug delivery for cancer chemotherapy. In vitro and in vivo applications in head and neck, breast and brain (glioblastoma) cancers will be shown. The HCCs and related carbon nanoparticles are also potent and selective antioxidants, able to annihilate large amounts of superoxide while converting the superoxide to molecular oxygen with no downstream radical formation. Moreover, the nanoparticles do not react with the important vasodilator nitric oxide. Extensive in vitro, electron paramagnetic resonance and in vivo studies have been done. Applications in the treatment of traumatic brain injury/haemorrhagic shock and stroke will be discussed.

This talk is part of the Materials Chemistry Research Interest Group series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.


© 2006-2024, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity